{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:49:40Z","timestamp":1761126580698},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,2,26]],"date-time":"2009-02-26T00:00:00Z","timestamp":1235606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s00774-009-0047-9","type":"journal-article","created":{"date-parts":[[2009,2,25]],"date-time":"2009-02-25T03:39:01Z","timestamp":1235533141000},"page":"435-443","source":"Crossref","is-referenced-by-count":40,"title":["Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid"],"prefix":"10.1007","volume":"27","author":[{"given":"Sedat","family":"Cetiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulsan Turkoz","family":"Sucak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevil Altundag","family":"Kahraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahika Zeynep","family":"Ak\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benay","family":"Kocakahyaoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibel Elif","family":"Gultekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Cetiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rauf","family":"Haznedar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,26]]},"reference":[{"key":"47_CR1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ncponc0688","volume":"4","author":"CR Dunstan","year":"2007","unstructured":"Dunstan CR, Felsenberg D, Seibel MJ (2007) Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease. Nat Clin Pract Oncol 4:42\u201355","journal-title":"Nat Clin Pract Oncol"},{"key":"47_CR2","first-page":"111","volume":"71","author":"MD Melo","year":"2005","unstructured":"Melo MD, Obeid G (2005) Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy. J Can Dent Assoc 71:111\u2013113","journal-title":"J Can Dent Assoc"},{"key":"47_CR3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.47102\/annals-acadmedsg.V33N4p48S","volume":"33","author":"NA Robinson","year":"2004","unstructured":"Robinson NA, Yeo JF (2004) Bisphosphonates\u2014a word of caution. Ann Acad Med Singap 33:48\u201349","journal-title":"Ann Acad Med Singap"},{"key":"47_CR4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.tripleo.2006.09.022","volume":"103","author":"R Diego","year":"2007","unstructured":"Diego R, D\u2019Orto O, Pagani D, Agazzi A, Marzano U, Derada Troletti G, Fontanella W, Pignataro L (2007) Bisphosphonate-associated osteonecrosis of the jaws\u2014a therapeutic dilemma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103:e1\u2013e5","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"47_CR5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","volume":"62","author":"SL Ruggiero","year":"2004","unstructured":"Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527\u2013534","journal-title":"J Oral Maxillofac Surg"},{"key":"47_CR6","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1172\/JCI114100","volume":"83","author":"DE Hughes","year":"1989","unstructured":"Hughes DE, MacDonald BR, Russell RG, Gowen M (1989) Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J Clin Invest 83:1930\u20131935","journal-title":"J Clin Invest"},{"issue":"88","key":"47_CR7","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","volume":"15","author":"MJ Rogers","year":"2000","unstructured":"Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, Frith JC (2000) Cellular and molecular mechanisms of action of bisphosphonates. Cancer 15(88):2961\u20132978","journal-title":"Cancer"},{"key":"47_CR8","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","volume":"10","author":"DE Hughes","year":"1995","unstructured":"Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, Boyce BF (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478\u20131487","journal-title":"J Bone Miner Res"},{"key":"47_CR9","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"key":"47_CR10","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2141.2006.06230.x","volume":"134","author":"K Zervas","year":"2006","unstructured":"Zervas K, Verrou E, Teleioudis Z, Vahysevanos K, Banti A, Mihou D, Krikelis D, Terpos E (2006) Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients. Br J Haematol 134:620\u2013623","journal-title":"Br J Haematol"},{"key":"47_CR11","unstructured":"Prophet EB, Mills B, Arrington JB, Sobin LH (1992) Laboratory methods in histotechnology. Armed Forces Institute of Pathology. AM Registry of Pathology Washington DC"},{"key":"47_CR12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0714.2004.00269.x","volume":"34","author":"JV Bagan","year":"2005","unstructured":"Bagan JV, Murillo J, Jimenez Y, Poveda R, Milian MA, Sanchis JM, Silvestre FJ, Scully C (2005) Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. J Oral Pathol Med 34:120\u2013123","journal-title":"J Oral Pathol Med"},{"key":"47_CR13","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.14219\/jada.archive.2005.0110","volume":"136","author":"MD Melo","year":"2005","unstructured":"Melo MD, Obeid G (2005) Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition. J Am Dent Assoc 136:1675\u20131681","journal-title":"J Am Dent Assoc"},{"key":"47_CR14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1053\/joms.2003.50095","volume":"61","author":"MA Pogrel","year":"2003","unstructured":"Pogrel MA, Miller CE (2003) A case of maxillary necrosis. J Oral Maxillofac Surg 61:489\u2013493","journal-title":"J Oral Maxillofac Surg"},{"key":"47_CR15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1054\/ijom.2002.0332","volume":"32","author":"T Reuther","year":"2003","unstructured":"Reuther T, Schuster T, Mende U, Kubler A (2003) Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients\u2014a report of a thirty year retrospective review. Int J Oral Maxillofac Surg 32:289\u2013295","journal-title":"Int J Oral Maxillofac Surg"},{"key":"47_CR16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tripleo.2006.06.004","volume":"102","author":"SL Ruggiero","year":"2006","unstructured":"Ruggiero SL, Fantasia J, Carlson E (2006) Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:433\u2013441","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"47_CR17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2141.2005.05382.x","volume":"128","author":"AM Vannucchi","year":"2005","unstructured":"Vannucchi AM, Ficarra G, Antonioli E, Bosi A (2005) Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma. Br J Haematol 128:738","journal-title":"Br J Haematol"},{"key":"47_CR18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","volume":"35","author":"T Hansen","year":"2006","unstructured":"Hansen T, Kunkel M, Weber A, Kirkpatrick CJ (2006) Osteonecrosis of the jaws in patients treated with bisphosphonates-histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 35:155\u2013160","journal-title":"J Oral Pathol Med"},{"key":"47_CR19","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00428-007-0516-2","volume":"451","author":"T Hansen","year":"2007","unstructured":"Hansen T, Kunkel M, Springer E, Walter C, Weber A, Siegel E, Kirkpatrick CJ (2007) Actinomycosis of the jaws-histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis. Virchows Arch 451:1009\u20131017","journal-title":"Virchows Arch"},{"key":"47_CR20","first-page":"318","volume":"13","author":"R Font Gomez","year":"2008","unstructured":"Font Gomez R, Garcia MLM, Martinez JMO (2008) Osteochemonecrosis of the jaws due to bisphosphonate treatments. Update. Med Oral Patol Oral Cir Bucal 13:318\u2013324","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"47_CR21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1601-0825.2007.01381.x","volume":"14","author":"J Sarin","year":"2008","unstructured":"Sarin J, DeRossi SS, Akintoye SO (2008) Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis. Oral Dis 14:277\u2013285","journal-title":"Oral Dis"},{"key":"47_CR22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","volume":"144","author":"SB Woo","year":"2006","unstructured":"Woo SB, Hellstein JW, Kalmar JR (2006) Narrative review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753\u2013761","journal-title":"Ann Intern Med"},{"key":"47_CR23","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/annonc\/mdl045","volume":"17","author":"M Ardine","year":"2006","unstructured":"Ardine M, Generali D, Donadio M et al (2006) Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw? Ann Oncol 17:1336\u20131337","journal-title":"Ann Oncol"},{"key":"47_CR24","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.4049\/jimmunol.172.4.2504","volume":"172","author":"K Suda","year":"2004","unstructured":"Suda K, Udugawa N, Sato N (2004) Suppression of osteoprotegrin expression by prostaglandin E2 crucially involved in lipopolysaccharide-induced osteoclast formation. J Immunol 172:2504\u20132508","journal-title":"J Immunol"},{"key":"47_CR25","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/S0149-2918(03)80327-2","volume":"25","author":"EC Li","year":"2003","unstructured":"Li EC, Davis LE (2003) Zoledronic acid: a new parenteral bisphosphonate. Clin Ther 25:2669\u20132708","journal-title":"Clin Ther"},{"key":"47_CR26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","volume":"353","author":"BG Durie","year":"2005","unstructured":"Durie BG, Katz M, Crowley J (2005) Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353:99\u2013102","journal-title":"N Engl J Med"},{"key":"47_CR27","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","volume":"23","author":"AO Hoff","year":"2008","unstructured":"Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M, Nooka A, Sayegh G, Guarneri V, Desrouleaux K, Cui J, Adamus A, Gagel RF, Hortobagyi GN (2008) Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23:826\u2013836","journal-title":"J Bone Miner Res"},{"key":"47_CR28","first-page":"1053","volume":"20","author":"C Poznak Van","year":"2006","unstructured":"Van Poznak C, Estilo C (2006) Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates. Oncology (Williston Park) 20:1053\u20131065","journal-title":"Oncology (Williston Park)"},{"key":"47_CR29","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","volume":"23","author":"A Bamias","year":"2005","unstructured":"Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA (2005) Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23:8580\u20138587","journal-title":"J Clin Oncol"},{"key":"47_CR30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/138920106779116919","volume":"7","author":"TM Moehler","year":"2006","unstructured":"Moehler TM, Hillengass J, Glasmacher A, Goldschmidt H (2006) Thalidomide in multiple myeloma. Curr Pharm Biotechnol 7:431\u2013440","journal-title":"Curr Pharm Biotechnol"},{"key":"47_CR31","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2006-07-033571","volume":"108","author":"P Tosi","year":"2006","unstructured":"Tosi P, Zamagni E, Cangini D, Tacchetti P, Di Raimondo F, Catalano L, D\u2019Arco A, Ronconi S, Cellini C, Offidani M, Perrone G, Ceccolini M, Brioli A, Tura S, Baccarani M, Cavo M (2006) Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone. Blood 108:3951\u20133952","journal-title":"Blood"},{"key":"47_CR32","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","volume":"63","author":"RE Marx","year":"2005","unstructured":"Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention and treatment. J Oral Maxillofac Surg 63:1567\u20131575","journal-title":"J Oral Maxillofac Surg"},{"key":"47_CR33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0035-1768(06)77080-2","volume":"107","author":"A Woeller","year":"2006","unstructured":"Woeller A, Gering A, Brix M, Bettega G, Lebeau J (2006) Bone necrosis of the jaws in five patients taking bisphosphonates. Rev Stomatol Chir Maxillofac 107:417\u2013422","journal-title":"Rev Stomatol Chir Maxillofac"},{"key":"47_CR34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.mlg.0000187398.51857.3c","volume":"116","author":"MC Farrugia","year":"2006","unstructured":"Farrugia MC, Summerlin DJ, Krowiak E, Huntley T, Freeman S, Borrowdale R, Tomich C (2006) Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates. Laryngoscope 116:115\u2013120","journal-title":"Laryngoscope"},{"key":"47_CR35","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.14219\/jada.archive.2006.0355","volume":"137","author":"American Dental Association Council on Scientific Affairs","year":"2006","unstructured":"American Dental Association Council on Scientific Affairs (2006) Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. J Am Dent Assoc 137:1144\u20131150","journal-title":"J Am Dent Assoc"},{"key":"47_CR36","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/01.don.0000186481.96169.cd","volume":"31","author":"H Katz","year":"2005","unstructured":"Katz H (2005) Endodontic implications of bisphosphonate-associated osteonecrosis of the jaws: a report of three cases. J Endod 31:831\u2013834","journal-title":"J Endod"},{"key":"47_CR37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.joms.2005.12.051","volume":"65","author":"MM Curi","year":"2007","unstructured":"Curi MM, Cossolin GS, Koga DH, Araujo SR, Feher O, Dos Santos MO, Zardetto C (2007) Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: report of 3 cases. J Oral Maxillofac Surg 65:349\u2013355","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-009-0047-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-009-0047-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-009-0047-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T22:05:14Z","timestamp":1710108314000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-009-0047-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,26]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["47"],"URL":"https:\/\/doi.org\/10.1007\/s00774-009-0047-9","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,26]]}}}